Skip to main content
Caplight Logo









Wuhan YZY Medical Science and Technology Co., Ltd.

Wuhan YZY Medical Science and Technology Co., Ltd.

Private
WuhanHealthcare & Life Scienceshttp://yzymed.com/

Last Round

Series B

Extension

Aug 26, 2021

Est. Valuation

$741.05M

Total Funding Raised

$103.81M

Company Overview

Wuhan YZY Medical Science and Technology Co., Ltd. is a biotechnology company that specializes in the research, development, production, and sales of individualized medical diagnostic products, including molecular diagnostic kits and liquid biopsy systems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

in vitro diagnosticsIVDmolecular diagnosticsprecision medicinecompanion diagnosticsPCR kitsnucleic acid extractionmedical device manufacturerbiotech equipmentFISHfluorescence in situ hybridizationCTC analyzerlab automationrazor and bladeclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wuhan YZY Medical Science and Technology Co., Ltd. Comparables

Compare Wuhan YZY Medical Science and Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Wuhan YZY Medical Science and Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amoy Diagnostics Co., Ltd.
83%
CapitalBio Technology Co., Ltd.
81%
Guangdong Hybribio Biotech Co Ltd
80%

Wuhan YZY Medical Science and Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionAug 26, 2021
Series BJun 16, 2021
Series AJul 1, 2020
Series A ExtensionDec 1, 2017

Wuhan YZY Medical Science and Technology Co., Ltd. Investors

Notable investors and investment history

Wuhan YZY Medical Science and Technology Co., Ltd. investors
InvestorRounds
Huimei CapitalSeries B Extension
Legend CapitalSeries B
The Entrepreneurship Relay FundSeries A Extension
CPESeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2021

    $39M round led by Legend Capital.

  • Jul 1, 2020

    $9M Series A round completed.

Wuhan YZY Medical Science and Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wuhan YZY Medical Science and Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wuhan YZY Medical Science and Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan
Year Founded2011
Last FundingAug 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?